Unexpectedly, India witnessed an increasing trend of mucormycosis in COVID-19 recovered patients during the second wave of the pandemic ( Gade et al., 2021 ).
← all excerpts
Delineating the impact of COVID-19 on antimicrobial resistance: An Indian perspective.
1
—
—